MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 10 analysts with an average price target of $322.58. This is a potential upside of $63.77 (24.64%) from yesterday's end of day stock price of $258.81.

Madrigal Pharmaceuticals's activity chart (see below) currently has 105 price targets and 98 ratings on display. The stock rating distribution of MDGL is 85.71% BUY, 11.43% HOLD and 2.86% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.41% with an average time for these price targets to be met of 279.53 days.

Highest price target for MDGL is $347, Lowest price target is $155, average price target is $322.58.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 01-Mar-2024. First documented stock forecast 29-Oct-2014.

Currently out of the existing stock ratings of MDGL, 30 are a BUY (85.71%), 4 are a HOLD (11.43%), 1 are a SELL (2.86%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

320

$61.19 (23.64%)

285

28 days ago

6/10 (60%)

$68.37 (27.17%)

410

Sell

155

$-103.81 (-40.11%)

154

1 months 2 days ago

10/11 (90.91%)

$-84.8 (-35.36%)

261

Buy

347

$88.19 (34.08%)

347

1 months 6 days ago

2/8 (25%)

$110.46 (46.70%)

177

Buy

336

$77.19 (29.82%)

203

2 months 5 days ago

13/14 (92.86%)

$113.09 (50.73%)

386

Buy

321

$62.19 (24.03%)

2 months 11 days ago

0/1 (0%)

$96.9 (43.24%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 279.53 days on average for the stock forecasts to be realized with a an average price target met ratio 71.41

Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Jonathan Wolleben works at JMP and has 12 price targets and 9 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Andrea Tan with highest potential upside - $116.19

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Matthew Luchini with lowest potential downside - -$147.81

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?